Associations between self-referral and health behavior responses to genetic risk information

Genome Medicine

Volumn 7, Issue 1, 2015, Pages

  Christensen, Kurt D ^a   Roberts, J Scott ^b   Zikmund Fisher, Brian J ^b   Kardia, Sharon L R ^b   McBride, Colleen M ^c   Linnenbringer, Erin ^d   Green, Robert C ^e  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b UNIVERSITY OF MICHIGAN SCHOOL OF PUBLIC HEALTH   (United States)

^c EMORY UNIVERSITY   (United States)

^d WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E;

ACTIVELY RECRUITED PARTICIPANT; ADULT; ADVANCE PLANNING; AFRICAN AMERICAN; AGE DISTRIBUTION; ALZHEIMER DISEASE; ALZHEIMER DISEASE ATTENTIVENESS; APOE GENE; ARTICLE; ATTENTION; ATTITUDE TO HEALTH; BEHAVIOR CHANGE; COHORT ANALYSIS; COMPARATIVE STUDY; CONTROLLED STUDY; COPING BEHAVIOR; DIET; DIET SUPPLEMENTATION; EXERCISE; FEMALE; GENETIC RISK; GENETIC SCREENING; GENETIC SUSCEPTIBILITY; GENOTYPE; HEALTH BEHAVIOR; HEALTH CARE PLANNING; HEALTH INSURANCE; HUMAN; INCOME; LONG TERM CARE INSURANCE; MAJOR CLINICAL STUDY; MALE; MEDICAL INFORMATION; MENTAL PERFORMANCE; MIDDLE AGED; MISCELLANEOUS NAMED GROUPS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK ASSESSMENT; SELF CONCEPT; SELF REFERRED PARTICIPANT;

EID: 84939127181     PISSN: None     EISSN: 1756994X     Source Type: Journal    
DOI: 10.1186/s13073-014-0124-0     Document Type: Article

References (46)

1. McBride CM, Koehly LM, Sanderson SC, Kaphingst KA. The behavioral response to personalized genetic information: will genetic risk profiles motivate individuals and families to choose more healthful behaviors? Annu Rev Public Health. 2010;31:89-103.
2. Marteau TM, French DP, Griffin SJ, Prevost AT, Sutton S, Watkinson C, et al. Effects of communicating DNA-based disease risk estimates on risk-reducing behaviours. Cochrane Database Syst Rev. 2010;10:CD007275.
3. Chao S, Roberts JS, Marteau TM, Silliman R, Cupples LA, Green RC. Health behavior changes after genetic risk assessment for Alzheimer disease: the REVEAL Study. Alzheimer Dis Assoc Disord. 2008;22:94-7.
4. Vernarelli JA, Roberts JS, Hiraki S, Chen CA, Cupples LA, Green RC. Effect of Alzheimer disease genetic risk disclosure on dietary supplement use. Am J Clin Nutr. 2010;91:1402-7.
5. Taylor Jr DH, Cook-Deegan RM, Hiraki S, Roberts JS, Blazer DG, Green RC. Genetic testing for Alzheimer's and long-term care insurance. Health Aff. 2010;29:102-8.
6. Zick CD, Mathews CJ, Roberts JS, Cook-Deegan R, Pokorski RJ, Green RC. Genetic testing for Alzheimer's disease and its impact on insurance purchasing behavior. Health Aff. 2005;24:483-90.
7. Angrist M. We are the genes we've been waiting for: rational responses to the gathering storm of personal genomics. Am J Bioeth. 2009;9:30-1.
8. O'Daniel J. The prospect of genome-guided preventive medicine: a need and opportunity for genetic counselors. J Genet Couns. 2010;19:315-27.
9. Graves KD, Peshkin BN, Luta G, Tuong W, Schwartz MD. Interest in genetic testing for modest changes in breast cancer risk: implications for SNP testing. Public Health Genomics. 2011;14:178-89.
10. Roberts JS, Connell CM. Illness representations among first-degree relatives of people with Alzheimer disease. Alzheimer Dis Assoc Disord. 2000;14:129-36.
11. DeBar LL, Yarborough BJ, Striegel-Moore RH, Rosselli F, Perrin N, Wilson GT, et al. Recruitment for a guided self-help binge eating trial: potential lessons for implementing programs in everyday practice settings. Contemp Clin Trials. 2009;30:326-33.
12. Snyder DC, Sloane R, Lobach D, Lipkus IM, Peterson B, Kraus W, et al. Differences in baseline characteristics and outcomes at 1- and 2-year follow-up of cancer survivors accrued via self-referral versus cancer registry in the FRESH START diet and exercise trial. Cancer Epidemiol Biomarkers Prev. 2008;17:1288-94.
13. Henrikson NB, Harris JN, Bowen DJ. Predictors of self-referral into a cancer genetics registry. Cancer Epidemiol Biomarkers Prev. 2007;16:1387-92.
14. Scholle SH, Peele PB, Kelleher KJ, Frank E, Jansen-McWilliams L, Kupfer D. Effect of different recruitment sources on the composition of a bipolar disorder case registry. Soc Psychiatry Psychiatr Epidemiol. 2000;35:220-7.
15. McBride CM, Curry SJ, Grothaus LC, Rosner D, Louie D, Wagner EH. Use of self-help materials and smoking cessation among proactively recruited and volunteer intervention participants. Am J Health Promot. 1998;12:321-4.
16. Roberts JS, Barber M, Brown TM, Cupples LA, Farrer LA, LaRusse SA, et al. Who seeks genetic susceptibility testing for Alzheimer's disease? Findings from a multisite, randomized clinical trial. Genet Med. 2004;6:197-203.
17. Roberts JS, Christensen KD, Green RC. Using Alzheimer's disease as a model for genetic risk disclosure: implications for personal genomics. Clin Genet. 2011;80:407-14.
18. Green RC, Roberts JS, Cupples LA, Relkin NR, Whitehouse PJ, Brown T, et al. Disclosure of APOE genotype for risk of Alzheimer's disease. N Engl J Med. 2009;361:245-54.
19. Roberts JS, Cupples LA, Relkin NR, Whitehouse PJ, Green RC. Genetic risk assessment for adult children of people with Alzheimer's disease: the Risk Evaluation and Education for Alzheimer's Disease (REVEAL) study. J Geriatr Psychiatry Neurol. 2005;18:250-5.
20. Teng EL, Chui HC. The modified mini-mental state (3MS) examination. J Clin Psychiatry. 1987;48:314-8.
21. Beck AT, Epstein N, Brown G, Steer RA. An inventory for measuring clinical anxiety: Psychometric properties. J Consult Clin Psychol. 1988;56:893-7.
22. Radloff LS. The CES-D Scale: a self report depression scale for research in the general population. Appl Psychol Meas. 1977;1:385-401.
23. Roberts JS, Chen CA, Uhlmann WR, Green RC. Effectiveness of a condensed protocol for disclosing APOE genotype and providing risk education for Alzheimer disease. Genet Med. 2012;14:742-8.
24. Hudson KL. Prohibiting genetic discrimination. N Engl J Med. 2007;356:2021-3.
25. Cupples LA, Farrer LA, Sadovnick AD, Relkin N, Whitehouse P, Green RC. Estimating risk curves for first-degree relatives of patients with Alzheimer's disease: the REVEAL Study. Genet Med. 2004;6:192-6.
26. Christensen KD, Roberts JS, Royal CDM, Fasaye G-A, Obisesan T, Cupples LA, et al. Incorporating ethnicity into genetic risk assessment for Alzheimer disease: the REVEAL Study experience. Genet Med. 2008;10:207-14.
27. Christensen KD, Roberts JS, Uhlmann WR, Green RC. Changes to perceptions of the pros and cons of genetic susceptibility testing after APOE genotyping for Alzheimer disease risk. Genet Med. 2011;13:409-14.
28. Radimer K, Bindewald B, Hughes J, Ervin B, Swanson C, Picciano MF. Dietary supplement use by US adults: data from the National Health and Nutrition Examination Survey, 1999-2000. Am J Epidemiol. 2004;160:339-49.
29. R Development Core Team R. A language and environment for statistical computing. 311th ed. Vienna, Austria: R Foundation for Statistical Computing; 2014.
30. van Buuren S, Groothuis-Oudshoorn K. MICE: multivariate imputation by chained equations in R. J Stat Softw. 2011;45:1-67.
31. Collins LM, Schafer JL, Kam C-M. A comparison of inclusive and restrictive strategies in modern missing data procedures. Psychol Methods. 2001;6:330-51.
32. Strecher VJ, Kreuter MW. The psychosocial and behavioral impact of health risk appraisals. In: Croyle RT, editor. Psychosocial effects of screening for disease prevention and detection. New York: Oxford University Press; 1995. p. 126-43.
33. Prochaska JO, Redding CA, Evers KE. The transtheoretical model and stages of change. In: Glanz K, Rimer BK, Viswanath K, editors. Health behavior and health education theory, research and practice. 4th ed. San Francisco: Jossey-Bass; 2008. p. 97-121.
34. Middleton A, Patch C, Wiggins J, Barnes K, Crawford G, Benjamin C, et al. Position statement on opportunistic genomic screening from the Association of Genetic Nurses and Counsellors (UK and Ireland). Eur J Hum Genet. 2014;22:955-6.
35. Burke W, Matheny Antommaria AH, Bennett R, Botkin J, Clayton EW, Henderson GE, et al. Recommendations for returning genomic incidental findings? We need to talk! Genet Med. 2013;15:854-9.
36. Wolf SM, Lawrenz FP, Nelson CA, Kahn JP, Cho MK, Clayton EW, et al. Managing incidental findings in human subjects research: analysis and recommendations. J Law Med Ethics. 2008;36:219-48.
37. Green RC, Berg JS, Grody WW, Kalia SS, Korf BR, Martin CL, et al. ACMG recommendations for reporting of incidental findings in clinical exome and genome sequencing. Genet Med. 2013;15:565-74.
38. Caulfield T. Direct-to-consumer testing: if consumers are not anxious, why are policymakers? Hum Genet. 2011;130:23-5.
39. Eng C, Sharp RR. Bioethical and clinical dilemmas of direct-to-consumer personal genomic testing: the problem of misattributed equivalence. Sci Transl Med. 2010;2:17cm15.
40. Roberts JS, Ostergren J. Direct-to-consumer genetic testing and personal genomics services: a review of recent empirical studies. Curr Genet Med Rep. 2013;1:182-200.
41. Mouchawar J, Hensley-Alford S, Laurion S, Ellis J, Kulchak-Rahm A, Finucane ML, et al. Impact of direct-to-consumer advertising for hereditary breast cancer testing on genetic services at a managed care organization: a naturally-occurring experiment. Genet Med. 2005;7:191-7.
42. Hurley D. Direct-to-consumer genetic tests for Alzheimer disease and more hit market: what to tell your patients. Neurol Today. 2008;8:22-3.
43. Hipps YG, Roberts JS, Farrer LA, Green RC. Differences between African Americans and whites in their attitudes toward genetic testing for Alzheimer's disease. Genet Test. 2003;7:39-44.
44. Alford SH, McBride CM, Reid RJ, Larson EB, Baxevanis AD, Brody LC. Participation in genetic testing research varies by social group. Public Health Genomics. 2011;14:85-93.
45. Schwarz N. Judgment in a social context: biases, shortcomings, and the logic of conversation. In: Zanna MP, editor. Advances in social psychology. Volume 26. San Diego, CA: Academic Press, Inc; 1994. p. 123-62.
46. Williams JW, Plassman BL. Burke J, Benjamin S: Preventing Alzheimer's disease and cognitive decline. Evid Rep Technol Assess (Full Rep). 2010;193:1-727.